Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo ; volume:24 ; number:1 ; day:4 ; month:11 ; year:2024 ; pages:1-14 ; date:12.2024
BMC cancer ; 24, Heft 1 (4.11.2024), 1-14, 12.2024
- Creator
-
Ji, Yanhao
Harris, Michael A.
Newton, Lucas M.
Harris, Tiffany J.
Fairlie, W. Douglas
Lee, Erinna F.
Hawkins, Christine J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-13088-7
- URN
-
urn:nbn:de:101:1-2501222103362.247432008128
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ji, Yanhao
- Harris, Michael A.
- Newton, Lucas M.
- Harris, Tiffany J.
- Fairlie, W. Douglas
- Lee, Erinna F.
- Hawkins, Christine J.
- SpringerLink (Online service)
Other Objects (12)
MCL.
MCXLI. - MCL.
Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
1221-1231, Casus MCL - MCLV
PorthoMCL: Parallel orthology prediction using MCL for the realm of massive genome availability
MCL 50 (Modell 2): Bd. 3
MCL 50 (Modell 2): Bd. 8
MCL 50 (Modell 2): Bd. 9
MCL 50 (Modell 2): Bd. 11
MCL 50 (Modell 2): Bd. 16
MCL 50 (Modell 2): Bd. 14
MCL 50 (Modell 2): Bd. 1
MCL.
MCXLI. - MCL.
Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
1221-1231, Casus MCL - MCLV
PorthoMCL: Parallel orthology prediction using MCL for the realm of massive genome availability
MCL 50 (Modell 2): Bd. 3
MCL 50 (Modell 2): Bd. 8
MCL 50 (Modell 2): Bd. 9
MCL 50 (Modell 2): Bd. 11
MCL 50 (Modell 2): Bd. 16
MCL 50 (Modell 2): Bd. 14
MCL 50 (Modell 2): Bd. 1
MCL.
MCXLI. - MCL.
Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
1221-1231, Casus MCL - MCLV
PorthoMCL: Parallel orthology prediction using MCL for the realm of massive genome availability
MCL 50 (Modell 2): Bd. 3
MCL 50 (Modell 2): Bd. 8
MCL 50 (Modell 2): Bd. 9
MCL 50 (Modell 2): Bd. 11
MCL 50 (Modell 2): Bd. 16
MCL 50 (Modell 2): Bd. 14